| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd (TEVA) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 9 sells. TEVA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 367.6K | $11.57M | - | |
| VP | 63.6K | $2.00M | - | |
| Other | 52.8K | $1.66M | - | |
| Other | 52.7K | $1.66M | - | |
| VP | 13.0K | $410.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2018 | Nazzi Gianfranco | EVP, Growth Markets Commercial | Sale+OE | 461 | $19.50 | $8,988.58 | -8.0% | |
| Mar 12, 2018 | Griffin Deborah A | Chief Accounting Officer | Sale+OE | 952 | $19.49 | $18,553.53 | -100% | |
| Mar 12, 2018 | Dethlefs Sven | EVP Global Marketing&Portfolio | Sale+OE | 576 | $19.49 | $11,225.66 | -13.1% | |
| Mar 12, 2018 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 714 | $19.50 | $13,921.57 | -100% | |
| Mar 5, 2018 | Griffin Deborah A | Chief Accounting Officer | Sale+OE | 773 | $19.38 | $14,980.74 | -100% | |
| Mar 5, 2018 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 1,108 | $19.28 | $21,362.24 | -100% | |
| Mar 5, 2018 | O'Grady Brendan P. | EVP, North America Commercial | Sale+OE | 705 | $19.38 | $13,662.90 | -33.7% | |
| Feb 15, 2018 | Sabag Mark | EVP, Global Human Resources | Sell | 5,050 | $19.68 | $99,382.50 | -5.5% |